Inclusion Criteria:  Those who are over 19 years old at the screening visit Those who do not have clinically significant congenital or chronic diseases and have no pathological symptoms or findings upon medical examination at the screening visit Those who determined as suitable study subjects by the principal investigator A person who signs the consent form at will, after hearing and understanding a sufficient explanation of the purpose, contents, characteristics of the investigational product, and expected adverse reactions of this clinical trial  Exclusion Criteria:  Those who have a clinically significant disease or have a history of such disease Those who have a history of gastrointestinal surgery Those who have taken drugs that induce and inhibit metabolism enzymes such as barbital drugs Those who participated in other clinical trials or bioequivalence studies and administered the investigational products within 6 months of the first administration date. Those who donated whole blood within 2 months or donated components within 2 weeks, or received a blood transfusion within 1 month of the first administration date